Distinctive electrophysiological characteristics of right ventricular out-flow tract cardiomyocytes

J Cell Mol Med. 2014 Aug;18(8):1540-8. doi: 10.1111/jcmm.12329. Epub 2014 Jun 9.

Abstract

Ventricular arrhythmias commonly originate from the right ventricular out-flow tract (RVOT). However, the electrophysiological characteristics and Ca(2+) homoeostasis of RVOT cardiomyocytes remain unclear. Whole-cell patch clamp and indo-1 fluorometric ratio techniques were used to investigate action potentials, Ca(2+) homoeostasis and ionic currents in isolated cardiomyocytes from the rabbit RVOT and right ventricular apex (RVA). Conventional microelectrodes were used to record the electrical activity before and after (KN-93, a Ca(2+) /calmodulin-dependent kinase II inhibitor, or ranolazine, a late sodium current inhibitor) treatment in RVOT and RVA tissue preparations under electrical pacing and ouabain (Na(+) /K(+) ATPase inhibitor) administration. In contrast to RVA cardiomyocytes, RVOT cardiomyocytes were characterized by longer action potential duration measured at 90% and 50% repolarization, larger Ca(2+) transients, higher Ca(2+) stores, higher late Na(+) and transient outward K(+) currents, but smaller delayed rectifier K(+) , L-type Ca(2+) currents and Na(+) -Ca(2+) exchanger currents. RVOT cardiomyocytes showed significantly more pacing-induced delayed afterdepolarizations (22% versus 0%, P < 0.05) and ouabain-induced ventricular arrhythmias (94% versus 61%, P < 0.05) than RVA cardiomyocytes. Consistently, it took longer time (9 ± 1 versus 4 ± 1 min., P < 0.05) to eliminate ouabain-induced ventricular arrhythmias after application of KN-93 (but not ranolazine) in the RVOT in comparison with the RVA. These results indicate that RVOT cardiomyocytes have distinct electrophysiological characteristics with longer AP duration and greater Ca(2+) content, which could contribute to the high RVOT arrhythmogenic activity.

Keywords: arrhythmogenicity; calcium handling; right ventricular out-flow tract; ventricular arrhythmias.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetanilides / pharmacology
  • Action Potentials
  • Animals
  • Arrhythmias, Cardiac / metabolism
  • Arrhythmias, Cardiac / pathology*
  • Benzylamines / pharmacology
  • Brugada Syndrome
  • Calcium / metabolism*
  • Cardiac Conduction System Disease
  • Electrophysiological Phenomena
  • Enzyme Inhibitors / pharmacology
  • Heart Conduction System / abnormalities*
  • Heart Conduction System / drug effects
  • Heart Conduction System / metabolism
  • Heart Conduction System / pathology
  • Heart Ventricles / cytology
  • Heart Ventricles / drug effects
  • Heart Ventricles / physiopathology*
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / physiology*
  • Patch-Clamp Techniques
  • Piperazines / pharmacology
  • Protein Kinase Inhibitors / pharmacology
  • Rabbits
  • Ranolazine
  • Sodium-Calcium Exchanger
  • Sulfonamides / pharmacology

Substances

  • Acetanilides
  • Benzylamines
  • Enzyme Inhibitors
  • Piperazines
  • Protein Kinase Inhibitors
  • Sodium-Calcium Exchanger
  • Sulfonamides
  • KN 93
  • Ranolazine
  • Calcium